Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
UBS
Boehringer Ingelheim
Medtronic
Express Scripts
Citi
Teva
Deloitte
Julphar
McKesson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Desmopressin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desmopressin acetate and what is the scope of desmopressin acetate patent protection?

Desmopressin acetate
is the generic ingredient in ten branded drugs marketed by Ferring Pharms Inc, Bedford, Hospira, Sagent Pharms, Sun Pharm Inds Ltd, Teva Pharms Usa, Ferring, Sun Pharm Inds, Bausch And Lomb, Apotex Inc, Sun Pharma Global, Zydus Pharms Usa Inc, Avadel Speclt, Actavis Labs Fl Inc, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, and Mylan Pharms Inc, and is included in twenty-six NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Desmopressin acetate has eighty-seven patent family members in thirty countries.

There are twenty drug master file entries for desmopressin acetate. Twenty-four suppliers are listed for this compound.
Summary for desmopressin acetate

US Patents and Regulatory Information for desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring MINIRIN desmopressin acetate SPRAY, METERED;NASAL 021333-001 Sep 16, 2002 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Avadel Speclt NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds DESMOPRESSIN ACETATE desmopressin acetate SOLUTION;NASAL 077212-001 Apr 12, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Avadel Speclt NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bedford DESMOPRESSIN ACETATE PRESERVATIVE FREE desmopressin acetate INJECTABLE;INJECTION 074574-001 Feb 18, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc STIMATE desmopressin acetate SPRAY, METERED;NASAL 020355-001 Mar 7, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 078271-001 Dec 23, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Heritage Pharma DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 207880-001 May 26, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-002 Apr 25, 1995 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate INJECTABLE;INJECTION 018938-001 Mar 30, 1984 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-002 Sep 6, 1995 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 017922-003 Aug 7, 1996 ➤ Subscribe ➤ Subscribe
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for desmopressin acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,220,747 Methods using desmopressin acetate in orodispersible form ➤ Subscribe
7,560,429 Orodispersible dosage forms of desmopressin acetate ➤ Subscribe
7,947,654 Pharmaceutical formulations ➤ Subscribe
9,504,647 Pharmaceutical formulations of desmopressin ➤ Subscribe
8,802,624 Methods of treatment using orodispersible desmopressin pharmaceutical formulations ➤ Subscribe
8,143,225 Pharmaceutical compositions including low dosages of desmopressin ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for desmopressin acetate

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
Fish and Richardson
Teva
Boehringer Ingelheim
AstraZeneca
Cerilliant
Julphar
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot